Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis

NCT05824728 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease Psychosis

Interventions

DRUG: AGB101

Sponsor

Johns Hopkins University

Collaborators

[object Object]